Word getting out in Japan on Nikkei Biotech.
In Japan a drug can be licensed for off-label indication based on the evaluation of published literature - Rem-L is approved for GvHD - wonder if they'd consider it for Covid-19 based on the NIH data?
Japan is still seeing 2800 cases a day and it's not looking great for them with the Olympics coming up.
https://apnews.com/article/japan-coronavirus-pandemic-business-olympic-games-2020-tokyo-olympics-72cc0b10127e8bab06406a6ec6bcedd6“Osaka’s medical systems have collapsed,” said her son, Kazuyuki Akita. He has watched from his home north of Tokyo as three other family members in Osaka have dealt with the virus, and with inadequate health care. “It’s like hell.”
Hospitals in Osaka, Japan’s third-biggest city and only 2 1/2 hours by bullet train from Summer Olympics host Tokyo, are overflowing with coronavirus patients. About 35,000 people nationwide — twice the number of those in hospitals — must stay at home with the disease, often becoming seriously ill and sometimes dying before they can get medical care.
Cell Therapy News/Articles, page-9306
-
- There are more pages in this discussion • 8,940 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |